Chris M Pillar Selected Research

1 beta-methylcarbapenem

12/2008

In vitro activity of doripenem, a carbapenem for the treatment of challenging infections caused by gram-negative bacteria, against recent clinical isolates from the United States.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chris M Pillar Research Topics

Disease

4	Infections 02/2017 - 09/2004
2	Eye Infections 10/2011 - 08/2009
1	Invasive Fungal Infections 12/2019
1	Candidiasis (Moniliasis) 11/2017
1	Invasive Candidiasis 11/2017
1	Candidemia 11/2017
1	Urinary Tract Infections (Urinary Tract Infection) 04/2015
1	Bacterial Infections (Bacterial Infection) 01/2013
1	Bacterial Conjunctivitis 07/2010
1	Intraabdominal Infections 12/2008
1	Cross Infection (Nosocomial Infection) 03/2008

Drug/Important Bio-Agent (IBA)

5	Anti-Bacterial Agents (Antibiotics)IBA 04/2015 - 09/2004
3	FluoroquinolonesIBA 10/2011 - 08/2009
2	tedizolidIBA 02/2017 - 09/2012
2	besifloxacin FDA Link 07/2010 - 08/2009
1	ProdrugsIBA 12/2019
1	RezafunginIBA 11/2017
1	AzolesIBA 11/2017
1	EchinocandinsIBA 11/2017
1	dalbavancinIBA 02/2017
1	telavancin FDA Link 02/2017
1	oritavancinIBA 02/2017
1	Ceftaroline FDA Link 02/2017
1	LipoglycopeptidesIBA 02/2017
1	eravacyclineIBA 04/2015
1	tedizolid phosphateIBA 09/2012
1	LactamsIBA 10/2011
1	Cephalosporins (Cephalosporin Antibiotics)IBA 10/2011
1	Chloramphenicol (Chloromycetin)FDA Link 10/2011
1	GlycopeptidesIBA 10/2011
1	AminoglycosidesIBA 10/2011
1	MacrolidesIBA 10/2011
1	Doripenem FDA Link 12/2008
1	Carbapenems (Carbapenem Antibiotics)IBA 12/2008
1	1 beta-methylcarbapenemIBA 12/2008
1	ceftobiproleIBA 03/2008